Biofrontera Inc. provided revenue guidance for the fourth quarter and full year of 2021. For the fourth quarter of 2021, revenue is anticipated to be in a range of $9.1 million to $9.2 million, representing an increase of approximately 7% compared with the fourth quarter of 2020.

For the full year 2021, preliminary revenue is anticipated to be in the range of $24.1 million to $24.2million, an increase of approximately 27% over full year 2020.